{"id":112113,"date":"2017-04-25T19:31:41","date_gmt":"2017-04-25T19:31:41","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=112113"},"modified":"2017-04-25T19:31:41","modified_gmt":"2017-04-25T19:31:41","slug":"profacgen-launched-novel-services-for-preclinical-study-industry-manufacture-and-translational-research","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/profacgen-launched-novel-services-for-preclinical-study-industry-manufacture-and-translational-research_112113.html","title":{"rendered":"Profacgen Launched Novel Services for Preclinical Study, Industry Manufacture and Translational Research"},"content":{"rendered":"
\"\"<\/a><\/div>\n

Profacgen, an expert provider of protein-related products and services, recently made a great move—the launch of a series of novel services for scientists in the field of preclinical study, industry manufacture, and translational research.<\/p>\n

Profacgen has unparalleled capacity in delivering custom proteins in large preparative scale. It produces recombinant proteins and monoclonal antibodies according to customer specifications or by developing customized protocols in house. they understand exactly how process development studies and clinical trial manufacturing enter into its shared target of clinical development. As a team, the company have taken biopharmaceuticals from early concept studies all the way to successful market approval.<\/p>\n

This new launch mainly include four categories of services: Molecular Modeling, Drug Screening, Protein Manufacture and Protein Analysis. To be specific, services now available for industrial customers and drug discovery companies are:<\/p>\n

Homology Modeling
Membrane Protein Modeling<\/a>
Antibody Modeling
Fusion Protein Modeling<\/a>
Post-translational Modification
Molecular Dynamics Simulation<\/a>
Computer-aided Drug Design<\/p>\n

“We are always trying our best to serve our customers better and customize and expand our services to meet their increasing needs in the preclinical and industrial manufacture fields. With the release of those new services, we hope we can help accelerate their production and studies,” commented Crystal, the chief marketing staff in Profacgen.<\/p>\n

To know more about those newly launched services in Profacgen, please visit https:\/\/www.profacgen.com\/preclinicalhome.htm<\/a><\/p>\n

About Profacgen<\/strong><\/p>\n

Profacgen provides process development and cGMP manufacturing services for biological active ingredients. We have ready access to state-of-the-art biopharmaceutical product development and manufacturing facilities and our staff scientists have demonstrable expertise in all aspects of biopharmaceutical manufacturing, from facility design and operation to the ability to provide best advice relating to product development. We also save our clients a great deal of time with bioprocess scale-up services. Our fermentation laboratories are equipped with state-of-the-art fermentors and bioreactors that enable us to express protein in large scale. Our customers can choose to enter into the protein expression pipeline at any stage depending on their needs.<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Profacgen
Contact Person:<\/strong> Ellen Burns
Email:<\/strong> info@profacgen.com
Phone:<\/strong> 6316197922
Address:<\/strong>45-1 Ramsey Road
City:<\/strong> Shirley
State:<\/strong> New York
Country:<\/strong> United States
Website:<\/strong> www.profacgen.com\/preclinicalhome.htm<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Profacgen, an expert provider of protein-related products and services, recently made a great move—the launch of a series of novel services for scientists in the field of preclinical study, industry manufacture, and translational research. Profacgen has unparalleled capacity in delivering … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-112113","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/112113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=112113"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/112113\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=112113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=112113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=112113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}